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Abstract 
We aimed to compare the minimum p value method and the area under the receiver 
operating characteristics (ROC) curve approach to categorize continuous biomarkers 
for the prediction of postoperative 30-day major adverse cardiac events in noncardiac 
vascular surgery patients. Individual-patient data from six cohorts reporting B-type 
natriuretic peptide (BNP) or N-terminal pro-B-type natriuretic peptide (NTproBNP) were 
obtained. These biomarkers were dichotomized using the minimum p value method 
and compared with previously reported ROC curve-derived thresholds using logistic 
regression analysis. A final prediction model was developed, internally validated, and 
assessed for its sensitivity to clustering effects. Finally, a preoperative risk score sys-
tem was proposed. Thresholds identified by the minimum p value method and ROC 
curve approach were 115.57 pg/ml (p < 0.001) and 116 pg/ml for BNP, and 241.7 pg/
ml (p = 0.001) and 277.5 pg/ml for NTproBNP, respectively. The minimum p value 
thresholds were slightly stronger predictors based on our logistic regression analysis. 
The final model included a composite predictor of the minimum p value method’s BNP 
and NTproBNP thresholds [odds ratio (OR) = 8.5, p < 0.001], surgery type (OR = 2.5, 
p = 0.002), and diabetes (OR = 2.1, p = 0.015). Preoperative risks using the scoring 
system ranged from 2 to 49 %. The minimum p value method and ROC curve approach 
identify similar optimal thresholds. We propose to replace the revised cardiac risk index 
with our risk score system for individual-specific preoperative risk stratification after 
noncardiac nonvascular surgery.
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Background
There are over 200 million individuals receiving major noncardiac surgery worldwide 
annually (Ford et  al. 2010), many carrying a great risk of major adverse cardiovascu-
lar events (MACE), including myocardial infarction (MI) and mortality (Rodseth et al. 
2011). Preoperative risk-stratification to identify high-risk patients is used to improve 
perioperative management. The revised cardiac risk index (RCRI) (Lee et  al. 1999; 
Boersma et al. 2005; Fleisher et al. 2007; Poldermans et al. 2009) is the leading instru-
ment used, however it was derived from a heterogeneous noncardiac population, and 
is unable to produce individual-specific risk scores (Biccard and Rodseth 2011). A sys-
tematic review of the RCRI found that prediction of cardiac events (cardiac death, MI, 
and nonfatal cardiac arrest) are notably less accurate for noncardiac vascular surgery 
patients (Ford et al. 2010).
Two hormones, B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriu-
retic peptide (NTproBNP) have recently been investigated as prognostic biomarkers 
(Rajagopalan et  al. 2008, 2011; Rodseth et  al. 2008, 2011). They are released into the 
blood by ventricular cardiomyocytes when there is mechanical or ischemic strain on the 
atrial or ventricular wall (Rodseth et al. 2011; Harrison et al. 2002). Elevation in either of 
these hormone concentrations increase the risk of 30-day MACE (Rodseth et al. 2011; 
Karthikeyan et al. 2009). Optimal thresholds are under investigation.
Rodseth et  al. conducted an individual patient data meta-analysis and proposed 
thresholds of 116 pg/ml for BNP and 277.5 pg/ml for NTproBNP for predicting 30-day 
MACE (Rodseth et al. 2011). These values were identified using the receiver operating 
characteristic (ROC) curve approach for categorizing continuous variables (Cook 2008; 
Zhu et al. 2010). There are other less commonly used discrimination methods, such as 
the minimum p value method, which may identify a more predictive threshold. Com-
parisons between these methods have yet to be investigated.
We aimed to (1) explore the BNP and NTproBNP thresholds from Rodseth et al., (2) 
incorporate the best performing discrimination method into a final predictive model for 
30-day MACE after a noncardiac vascular surgery, and (3) propose a decision tool for 
clinicians to determine individual-patient risk. The secondary objectives were to explore 
individual prediction rules for all-cause mortality, cardiac death, and nonfatal MI within 
30 days after a vascular surgery.
Results
A total of 850 participants who received noncardiac nonvascular surgery were included 
in our dataset. Only 75 of these individuals experienced a MACE within 30 days (9 %). 
Participants had an average age of 65.4 years (sd = 12.1), and approximately half were 
males (391/850, 46  %). Seventy-five patients experienced MACE within 30  days while 
the modified RCRI used by Rodseth et al. predicted 54 (72 %) of these events. Of those 
who experienced a MACE, 56 % had a history of coronary artery disease (42/75), 25 % 
had a history of diabetes mellitus (25/75), 14 % had a history of congestive heart failure 
(14/75), and 8 % had a history of cerebrovascular disease (8/75). The type of surgery for 
four participants was not specified and these individuals were not included in our uni-
variate and multivariable analyses. None experienced a MACE within 30 days. Patient 
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characteristics are presented in Table  1 and additional participant information can be 
found in Rodseth et al.’s study (Rodseth et al. 2011).
Minimal p value method for obtaining thresholds
We excluded 0  pg/ml as a threshold and removed 5  % of outliers from BNP and 
NTproBNP. The remaining 303 BNP thresholds (range 2–2322  pg/ml) and 204 
NTproBNP thresholds (range 22–1572 pg/ml) were investigated. The thresholds corre-
sponding to the minimal p values for BNP and NTproBNP were 115.57 pg/ml (p < 0.001, 
χ2  =  88.79, df  =  1, RR  =  2.09) and 241.70  pg/ml (p  =  0.001, χ2  =  10.98, df  =  1, 
RR = 3.33), respectively (Figs. 1 and 2). These were very close to Rodseth et al.’s ROC 
thresholds (BNP: 116 pg/ml, NTproBNP: 277.5 pg/ml). Our p value adjustment optimal 
thresholds were statistically significant with MACE (pBNP  <  0.001, pNTproBNP  <  0.001). 
Rodseth’s ROC curve results for BNP and NTproBNP were 116 pg/ml (66 % sensitivity, 
82 % specificity) and 277.5 pg/ml, respectively (Rodseth et al. 2011). The final BNP and 
NTproBNP thresholds were combined to form our minimum p value method (MPM) 
threshold variable.
Table 1 Participant characteristics
yr years, SD standard deviation, P. Chi Pearson Chi square test, RCRI revised cardiac risk index, BNP B‑type natriuretic peptide, 
NTproBNP N‑terminal pro‑B‑type natriuretic peptide
a Analysis performed using t test
b Level not included in analysis
c Analysis performed with Mann‑U‑Whitney test; other variables were analyzed with Chi squared tests
Variable Total (n = 850) MACE30 (n = 75) NO MACE30 (n = 775) Test statistic p
Agea (yr): mean (SD) 65.4 (12.1) 69.4 (8.8) 65.0 (12.3) 3.07 0.002
Sex (men): n (%) 391 (46.0) 36 (48.0) 355 (45.8) 0.15 0.696
+Missing 218 (26.0)
Type of vascular surgery: 
n (%)
2.54 0.110
 (a) Infrainguinal 629 (74.0) 50 (66.7) 579 (74.7)
 (b) Aortoiliac 217 (25.5) 25 (33.3) 192 (24.8)
 (c) Not specifiedb 4 (0.5) 0 4 (0.5)
RCRI class: n (%) 12.50 0.002
 (a) Low (RCRI 0) 320 (37.6) 19 (25.3) 301 (38.8)
 (b) Intermediate (RCRI 
1 or 2)
476 (56.0) 45 (60.0) 431 (55.6)
 (c) High (RCRI 3) 54 (6.4) 11 (14.7) 43 (5.5)
RCRI components: n (%)
 Coronary artery disease 327 (38.5) 42 (56.0) 285 (36.8) 10.68 0.001
 Congestive heart failure 64 (7.5) 14 (18.7) 50 (6.5) 14.65 <0.001
 Cerebrovascular disease 145 (17.1) 8 (10.7) 137 (17.7) 2.38 0.123
 Diabetes mellitus 204 (24.0) 25 (33.3) 179 (23.1) 3.93 0.048
 Creatinine (≥2 mg/dl) 28 (3.3) 6 (8.0) 22 (2.8) 5.72 0.017
BNP: median (min, max) 132 (0, 3893) 12 (0, 3139) 6.54c <0.001c
NTproBNP: median (min, 
max)
534 (24, 25,780) 204 (5, 6172) 3.02c 0.003c
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Comparing logistic regression methods
The comparison between the previously reported model (ROC threshold, surgery type, 
and diabetes mellitus) with our model MPM threshold, surgery type, diabetes melli-
tus) are presented in Table 2. The MPM threshold had a slightly higher odds ratio and 
a smaller p value than the ROC threshold, indicating a stronger association with 30-day 
MACE. The new model had a larger AUC and a smaller AIC, indicating a better-fit. We 
used MPM threshold due to its slightly better overall performance.
Development of a final prediction model
We first evaluated the impact of each predictor in Rodseth et al.’s model by individually 
and then collectively adding diabetes and surgery type to a model with MPM thresh-
old. A model with only MPM threshold yielded a pMPM threshold < 0.001 and an AUC of 
Fig. 1 A minimum p value analysis demonstrating potential BNP threshold values and corresponding p val-
ues. This graph presents the corresponding p value of each Chi square test performed on a series of potential 
B-type natriuretic peptide (BNP) thresholds to predict 30-day MACE after vascular surgery. The threshold with 
the smallest p value is set as the optimal threshold for dichotomizing NTproBNP
Fig. 2 A minimum p value analysis demonstrating potential BNP threshold values and corresponding p val-
ues. This graph presents the corresponding p value of each Chi square test performed on a series of potential 
NTproBNP thresholds to predict 30-day MACE after vascular surgery. The threshold with the smallest p value 
is set as the optimal threshold for dichotomizing NTproBNP
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0.72. Diabetes was not significant when adjusting for MPM threshold (pdiabetes = 0.100, 
AUC = 0.74) while surgery type was (psurgerytype = 0.013, AUC = 0.76). In the full model, 
however, surgery type and diabetes were significant (Table 2).
We further investigated the MPM threshold with other significant predictors (p < 0.05) 
from our univariate analyses (Table  1): age greater than 65  years, history of coronary 
artery disease history, congestive cardiac failure history, diabetes mellitus, and renal 
insufficiency. We had a low number of observations for study 5 (n5 = 3), therefore we 
excluded these levels from our logistic regression analysis. The following predictors were 
significantly associated with 30-day MACE and were included in our final model: MPM 
threshold (OR = 8.5, 95 % CI 5.03–14.41, p < 0.001), surgery type (OR 2.5, 95 % CI 1.40–
4.60, p = 0.002), and diabetes (OR 2.1, 95 % CI 1.11–3.84, p = 0.023). The variance infla-
tion factors were all less than 1.2 and the tolerance levels for each explanatory variable 
were greater than or equal to 0.9, suggesting low multicollinearity among predictors. The 
final model is presented as the development model in Table 3, which also presents the 
results from our sensitivity and validation analysis.  
Validation and sensitivity analysis
Our internal validation model identified similar estimates as our final model (MPM 
threshold: OR 8.6, 95 % CI 4.95–14.65, p < 0.001; surgery type: OR 2.6, 95 % CI 1.37–
4.68, p = 0.004; diabetes: OR 2.1, 95 % CI 1.11–3.84, p = 0.023; AUC = 0.79). Diabetes 
was not a significant predictor in our mixed effects logistic regression model and our 
GEE (p > 0.05, α = 0.05). This indicates that some heterogeneity existed among the data. 
Figure 3 presents the results of each model, separated by predictor to clearly depict the 
variability between each model.
Table 2 Comparison of ROC and MPM thresholds using logistic regression analysis
ROC threshold is an indicator variable of BNP and NTproBNP thresholds determined by the ROC curve method (Allison 
2012); MPM threshold is an indicator variable of BNP and NTproBNP thresholds determined by the minimum p value 
method
Ref reference level, OR odds ratio, CI confidence interval, AUC area under the ROC curve
Models and predictors OR (95 % CI) p AUC AIC
ROC threshold
 BNP ≥ 116 pg/ml or NTproBNP ≥ 277.5 pg/ml; 8.4 (4.98,14.11) <0.001 0.768 431.63
 Ref = BNP < 116 or NTproBNP < 277.5 pg/ml
Surgery type
 Aortoiliac; Ref = Infrainguinal surgery 2.4 (1.33, 4.37) 0.004
Diabetes
 Yes; Ref = No 2.0 (1.10, 3.54) 0.023
MPM threshold
 BNP ≥ 115.57 pg/ml or NTproBNP ≥ 246.7 pg/ml; 8.5 (5.03, 14.41) <0.001 0.777 430.16
 Ref = BNP < 115.57 pg/ml or NTproBNP < 246.7 pg/ml
Surgery type
 Aortoiliac; Ref = Infrainguinal surgery 2.5 (1.40, 4.60) 0.002
Diabetes
 Yes; Ref = No 2.1 (1.15, 3.71) 0.015
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Producing a points system
We created a scoring system by first assigning a 0 point to each predictor’s reference level 
(the least unhealthy level). B, the number of regression units needed for one point in 
the scoring system and also the smallest regression coefficient in the model, was 0.7262 
(βminimum = βdiabetes = 0.7262). This was used to divide and round all remaining regres-
sion coefficients to obtain their corresponding points. History of diabetes was assigned 
a point of 1, BNP/NTproBNP concentration values greater than the MPM threshold a 
point of 3, and aortoiliac surgery a point of 1. Thus, individuals scheduled for noncardiac 
vascular surgery would receive a total score ranging from 0 to 5, which corresponds to 
an associated risk ranging from 2.49 to 49.10 % (Table 4).
Table 3 Determining a prediction model for 30-day MACE
ROC threshold is an indicator variable of BNP and NTproBNP thresholds determined by the ROC curve method (Allison 
2012); MPM threshold is an indicator variable of BNP and NTproBNP thresholds determined by the minimum p value 
method
Ref reference level, OR odds ratio, CI confidence interval, AUC area under the ROC curve
Models and predictors OR (95 % CI) p AUC
Development model
MPM threshold
 BNP ≥ 115.57 pg/ml or NTproBNP ≥ 241.7 pg/ml; 8.5 (5.03, 14.41) <0.001 0.777
 Ref = BNP < 115.57 pg/ml or NTproBNP < 241.7 pg/ml
Surgery type
 Aortoiliac; Ref = infrainguinal surgery 2.5 (1.40, 4.60) 0.002
Diabetes
 Yes; Ref = No 2.1 (1.15, 3.71) 0.015
Internal validation
MPM threshold
 BNP ≥ 115.57 pg/ml or NTproBNP ≥ 241.7 pg/ml; 8.6 (4.95, 14.65) <0.001 0.793
 Ref = BNP < 115.57 pg/ml or NTproBNP < 241.7 pg/ml
Surgery type
 Aortoiliac; Ref = infrainguinal surgery 2.6 (1.37, 4.68) 0.004
Diabetes
 Yes; Ref = No 2.1 (1.11, 3.84) 0.023
Sensitivity analysis
Mixed effects logistic regression model
 MPM threshold
  BNP ≥ 115.57 pg/ml or NTproBNP ≥ 241.7 pg/ml; 10 (5.59, 18.06) <0.001 0.776
  Ref = BNP < 115.57 pg/ml or NTproBNP < 241.7 pg/ml
 Surgery type
  Aortoiliac; Ref = infrainguinal surgery 2.8 (1.51, 5.31) 0.001
 Diabetes
  Yes; Ref = No 1.6 (0.83, 2.96) 0.17
Generalized estimating equation
 MPM threshold
  BNP ≥ 115.57 pg/ml or NTproBNP ≥ 241.7 pg/ml; 9.4 (3.81, 23.33) <0.001 N/A
  Ref = BNP < 115.57 pg/ml or NTproBNP < 241.7 pg/ml
 Surgery type
  Aortoiliac; Ref = infrainguinal surgery 2.7 (1.27, 5.73) 0.01
 Diabetes
  Yes; Ref = No 1.8 (0.95, 3.46) 0.072
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Secondary analyses
We produced mixed effect logistic regression models for our secondary outcomes (all-
cause mortality, cardiac death, and non-fatal MI) to account for the within or between 
study heterogeneity observed in our sensitivity analysis (Table 5). Diabetes was not sig-
nificant and was removed from all three models. The MPM threshold remained a statis-
tically significant prognostic factor for each outcome. Surgery type was not significantly 
associated with cardiac death. The AUCs of each model are greater than 0.7, demon-
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Fig. 3 Forest plot of final model, internal validation model, and sensitivity models. Four models were cre-
ated: (1) a final prediction model, (2) internal validation (IV) model, generalized estimating equations (GEE), 
and (3) mixed effects logistic regression (MELR) model with predictors MPM threshold, surgery type, and 
history of diabetes mellitus. This plot presents the odds ratio (OR), 95 % confidence interval (CI) and p value 
for each predictor of each model. MPM threshold is a composite predictor of BNP and NTproBNP thresholds 
determined by the minimum p value method [MPM threshold = 0 (reference) if BNP < 115.57 pg/ml or 
NTproBNP < 241.7 pg/ml; MPM threshold = 1 if BNP > 115.57 pg/ml or NTproBNP > 241.7 pg/ml). Surgery 
type is the type of noncardiac vascular surgery [infrainguinal (reference) vs. aortoiliac]. Diabetes is an indicator 
of whether or not an individual was diagnosed with diabetes [no (reference) vs. yes]
Table 4 Scoring system for 30-day preoperative risk
The point totals are determined by adding points for each level of the predictors MPM threshold, surgery type, and diabetes 
that matches each patient’s information. Percentages accumulate to more than 100 % due to rounding during point 
creation
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Discussion
We used data from six cohort studies (n = 832 participants) to propose an individual-
specific risk prediction scoring system for 30-day MACE after noncardiac vascular 
surgery, based on a combined threshold factor for BNP and NTproBNP concentration 
levels, surgery type, and history of diabetes mellitus. The points system derived from 
this prediction model can allow clinicians to determine patients’ risk, ranging from 2.49 
to 49.10  %, in real time. Thresholds for BNP and NTproBNP were derived using the 
minimum p value method, which had a slightly better performance than the ROC curve 
thresholds in our prediction model.
There are various methods for categorizing continuous variables (Williams et al. 2006). 
Some use clinically relevant thresholds which are arbitrary, and may not be representa-
tive of a predictor’s true prognostic capability. Others use data-dependent approaches 
such as splitting by the mean or by percentiles (25th, median, 75th). Outcome-based 
methods, such as the ROC curve approach and the minimum p value method, sys-
tematically identify an “optimal” threshold from a set of values, using statistical meth-
ods and clinical guidance. Previous studies have derived ROC thresholds and validated 
them using different approaches such as bootstrapping or leave one-out cross-valida-
tion (Nougaret et al. 2015). To our knowledge, no study has compared the ROC curve 
method to the minimum p value method to determine which will identify more informa-
tive thresholds. The BNP and NTproBNP thresholds themselves differ by 126.13  pg/
ml (115.57 and 241.70  pg/ml, respectively) due to their composition. The half-life of 
NTproBNP (120 min) is six times longer than that of BNP (20 mins), making NTproBNP 
concentration levels higher than BNP values (Weber and Hamm 2006).
Table 5 Prediction models for all-cause mortality, cardiac death, and non-fatal myocardial 
infarction
Three models for each secondary outcome are presented. MPM threshold is an indicator variable of BNP and NTproBNP 
optimal thresholds determined by the minimum p value method
Ref reference level, OR odds ratio, CI confidence interval, AUC area under the ROC curve
Models and predictors OR (95 % CI) p AUC
Outcome = all-cause mortality
 MPM threshold
  BNP ≥ 115.57 pg/ml or NTproBNP ≥ 241.7 pg/ml; 6.7 (2.76, 16.10) <0.001 0.714
  Ref = BNP < 115.57 pg/ml or NTproBNP < 241.7 pg/ml
 Surgery type
  Aortoiliac; Ref = infrainguinal surgery 2.8 (1.16,6.79) 0.022
Outcome = cardiac death
 MPM threshold
  BNP ≥ 115.57 pg/ml or NTproBNP ≥ 241.7 pg/ml; 9.2 (3.10, 27.37) <0.001 0.750
  Ref = BNP < 115.57 pg/ml or NTproBNP < 241.7 pg/ml
 Surgery type
  Aortoiliac; Ref = infrainguinal surgery 2.6 (0.91,7.64) 0.075
Outcome = nonfatal MI
 MPM threshold
  BNP > 115.57 pg/ml or NTproBNP > 241.7 pg/ml; 8.7 (4.60, 16.33) <0.001 0.787
  Ref = BNP < 115.57 pg/ml or NTproBNP < 241.7 pg/ml
 Surgery type
  Aortoiliac; Ref = infrainguinal surgery 2.1 (1.06,4.17) 0.034
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In our analysis of other predictors, surgery type was clinically important and was 
included in the final prediction model of 30-day MACE. It was not significant in the 
univariate analysis (p = 0.229), however it was significant in our multivariable model. In 
contrast, congestive heart failure was significant (p < 0.001) in our univariate analysis, 
however was excluded in the final model. Despite a small VIF (0.98), literature describes 
a strong association between this factor and BNP/NTproBNP concentration levels, thus 
to avoid potential collinearity it was excluded (Harrison et al. 2002; Maisel 2002). Our 
secondary analyses identified MPM threshold and surgery type as significant predic-
tors for our secondary outcomes of all-cause mortality and non-fatal MI. For our cardiac 
death outcome, only MPM threshold was statistically significant. Further exploration of 
prognostic factors is needed to see the impact of MPM threshold on each outcome and 
to determine optimal prediction rules.
This study has three key strengths. First, we compared the performance of methods 
that are widely used for categorizing continuous predictors. Second, we present an inter-
nally-valid prediction model for 30-day MACE based on easily attainable measures and 
robust thresholds. Third, we describe an easy method to convert regression coefficients 
into risk-prediction scores, which simplifies preoperative risk classification for clinicians.
This study had several limitations. First, we used a composite predictor for BNP 
and NTproBNP, since no study reported both measures. NTproBNP has a more stable 
composition with possibly less sensitivity to sudden haemodynamic shifts, making it a 
potentially better biomarker than BNP for adverse outcomes (Rodseth et al. 2008; Rod-
seth 2009). However, limited data on NTproBNP was available (n = 218 participants), 
and the differing optimal thresholds derived using the minimum p value method and 
the ROC curve approach suggested that they were less robust than the BNP thresholds. 
Second, the minimum p value method is subject to inflation of Type I error rates (Far-
aggi and Simon 1996) however we adjusted for this using three formulae to reassess our 
p values. Third, in our regression analysis, we excluded the ‘not specified’ level of surgery 
type while Rodseth et al.’s included it (Rodseth et al. 2011). This may explain the slight 
discrepancy between our ROC threshold variable and their’s. We used different statisti-
cal software to run our analyses, and were unable to check the impact of excluding this 
level.
Future research should further investigate NTproBNP to finalize its optimal thresh-
old, and to determine whether it outperforms BNP in risk prediction. Furthermore, a 
twofold cross-validation technique could be used to identify optimal thresholds with 
relatively accurate type I error rates and unbiased estimates of effect size (Maisel 2002; 
Faraggi and Simon 1996), however larger datasets are required (Faraggi and Simon 1996; 
Mazumdar et al. 2003). Also, comparing reclassification of patients using the RCRI and 
using our final prediction model would confirm which approach was more appropriate 
for pre-operative risk prediction among vascular surgery patients. Lastly, our proposed 
prediction score should be investigated in the clinical setting to evaluate its impact on 
patient outcomes and overall perioperative management.
Conclusions
The minimum p value method presents similar optimal thresholds as the ROC curve 
approach in prediction of 30-day MACE after noncardiac vascular surgery. We propose 
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to replace the RCRI with our risk score system. Reclassification of patients using the 
RCRI and our final prediction model, along with further investigation of NTproBNP, 
should be performed to validate our thresholds and determine the most optimal model 
for pre-operative risk prediction among vascular surgery patients.
Methods
Study population
We used data from a previously conducted individual patient data meta-analysis (Rod-
seth et al. 2011). Briefly, six cohort studies on patients receiving elective noncardiac vas-
cular surgery (n = 850) investigated associations between preoperative BNP/NTproBNP 
concentration levels and postoperative cardiovascular outcomes within 30-days, includ-
ing all-cause mortality, cardiac death, non-fatal MI, and MACE (composite of all-cause 
mortality and non-fatal MI). Five studies reported BNP (n = 632 participants) (Bolliger 
et al. 2009; Biccard and Naidoo 2011; Cuthbertson et al. 2007; Gibson et al. 2007; Lei-
bowitz et  al. 2008), and one reported NTproBNP (n =  218 participants) (Mahla et  al. 
2007) concentration levels. No study reported both measurements. Participant charac-
teristics were reported as mean and standard deviation (sd) for continuous variables, 
and counts and percentages for categorical variables. BNP and NTproBNP are skewed 
continuous variables and were reported using medians, minimum and maximum values.
Comparison of methods
ROC curve approach
The ROC curve approach is used to measure the accuracy of a test in determining a 
dichotomous outcome (Maisel 2002). This approach determines an optimal threshold 
that has the highest accuracy for the prediction of a dichotomous outcome. A graphical 
presentation of an ROC curve reveals 1-specificity values (false positive rate, x-axis) and 
the sensitivity values (true positive rate, y-axis) for each potential threshold. Previously, 
optimal thresholds of 116 pg/ml for BNP (66 % sensitivity, 82 % specificity) and 277.5 pg/
ml for NTproBNP (unspecified sensitivity/specificity) were identified. Since no indi-
vidual reported both BNP and NTproBNP measures, these thresholds were combined 
into one indicator variable, hereafter referred to as the ROC threshold. Investigation of 
other prognostic factors revealed a final logistic regression model with ROC threshold, 
type of surgery, and diabetes mellitus as significant prognostic factors of 30-day MACE. 
This model was reproduced to make appropriate comparisons between the ROC curve 
approach and the minimum p value method.
Minimum p value method
The minimum p value method is another method to determine critical thresholds of 
dichotomous outcomes. A portion of extreme values are removed and each remaining 
observation is assessed as a potential threshold (Harrison et al. 2002). Chi squared tests 
were used to test the significant difference between the two groups (low vs. high risk) 
for 30-day MACE at each threshold. The threshold with the smallest p value is identi-
fied as the optimal cut-point where individuals with elevated levels beyond the thresh-
old are considered to have a high risk of 30-day MACE. The Chi square statistics (χ2), 
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corresponding p values (p), degrees of freedom (df ), and relative risk (RR) measures are 
reported for the final BNP and NTproBNP thresholds.
Inflation of Type 1 error caused by multiple-testing can arise and inflate the p values. 
We evaluated three formulae designed to reduce type I error inflation by adjusting the p 
values for each of the final BNP and NTproBNP thresholds (Mazumdar and Glassman 
2000). The smallest p value between two of these formulae (Miller and Siegmund’s 1982; 
Lausen and Schumaker’s 1996) was used to determine if each threshold was statistically 
significant (p < 0.05). These two final cut points were combined into one indicator vari-
able, hereafter referred to as the minimum p value method threshold (MPM threshold).
Comparing methods
We compared the odds ratios (ORs) and corresponding p values of BNP and NTproBNP 
thresholds using two logistic regression models, the previously reported model (ROC 
threshold, surgery type, and diabetes mellitus) and a new model (MPM threshold, sur-
gery type, diabetes mellitus). A stronger association of the MPM or ROC threshold with 
30-day MACE was implied by a higher OR and a smaller p value. Goodness-of-fit statis-
tics for both models were compared, where a better-fit model had a higher area under 
the ROC curve (AUC) and lower Akaike information criteria (AIC). We used RStudio-
Version 0.96.316 software (RStudio 2012) for the minimum p value method. All other 
analyses were performed in Version 9.3 of SAS (Cary, NC).
Determining a prediction model for 30‑day MACE
Development of a final prediction model
The primary predictor was the optimal threshold variable (MPM or ROC). Other 
prognostic factors of 30-day MACE were type of surgery (infra-inguinal or aorto-
iliac); patient age; and history of diabetes mellitus, congestive cardiac failure, coronary 
artery disease, cerebrovascular disease, and renal failure (creatinine >2  mg/dl). These 
were evaluated using t-tests or Chi square tests for continuous or categorical variables, 
respectively. Significant predictors (p < 0.05) were added to the model using a hierar-
chical approach. Final prognostic factors were assessed for multicollinearity with the 
variance inflation factor (VIF), where a VIF greater than 10 indicated high collinearity 
(Allison 2012).
Internal validation via bootstrapping
We produced logistic regression models for 1000 bootstrapped samples, sampled with 
replacement, from our dataset (Fox 2002). We averaged these models to produce a final 
validation model to compare the ORs, 95 % CIs, p values, and the AIC with our predic-
tion model.
Sensitivity analysis
To test whether our final model was sensitive to potential clustering effects created from 
our multi-leveled data structure, we compared our estimates with a mixed effects logistic 
regression model and generalized estimating equations (GEE). Our mixed effects logistic 
regression model was comprised of fixed effects (the covariates) and one random effect 
(study). The error and random effect term are assumed to follow a normal distribution 
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with a mean of zero (Heo and Leon 2005). Our GEE assumed an exchangeable correla-
tion matrix to consider a constant correlation between responses within a study and the 
same correlation structure was assumed across studies (Neuhaus et al. 1991).
Producing a points system for preoperative risk of 30‑day MACE
We produced a points system based on our final model. The reference level of each vari-
able from our regression analysis was the least unhealthy state, and assigned a value of 
0 (WiREF). Each additional level outside the reference level was given a positive value of 
(e.g. 1, 2). These levels were referred to as Wij, for the jth level of the ith predictor vari-
able. We then calculated points for each level using:
where, βˆi, is the parameter estimate for the ith predictor variable and B is the smallest 
parameter estimate (βmin) among all of the regression coefficients in the model. B repre-
sents the number of regression units needed for one point in the scoring system. Using 
an approximation of the logistic regression formula, we created point totals (rounded 
to the nearest whole number) and corresponding risk estimates for all possible patient 
profiles (Sullivan et al. 2004).
Secondary analyses
Exploratory analysis was performed to see if the same model could predict the individual 
components of 30-day MACE including all-cause mortality, cardiac death, and non-fatal 
MI.
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